Literature DB >> 319671

Successful treatment of Candida endophthalmitis with a synergistic combination of amphotericin B and rifampin.

P Lou, J Kazdan, R M Bannatyne, R Cheung.   

Abstract

Candida endophthalmitis, caused by transient candidemia, developed in a 14-year-old white girl receiving intravenous hyperalimentation. Antifungal synergism was established in vitro for the combination of amphotericin B and rifampin against the C. albicans isolate. A combined ten-day course of intravenous amphotericin B and oral rifampin was followed by the elimination of the infection and the preservation of good visual acuity.

Entities:  

Mesh：

Substances：

Year:  1977        PMID： 319671     DOI： 10.1016/0002-9394(77)90183-0

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN： 0002-9394            Impact factor:   5.258


  4 in total

1.  Intraocular penetration of rifampin after oral administration.

Authors:  K W Wong; D J D'Amico; B S Oum; P A Baker; K R Kenyon
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1990       Impact factor: 3.117

2.  Chemotherapy of experimental endogenous Candida albicans endophthalmitis.

Authors:  D B Jones
Journal:  Trans Am Ophthalmol Soc       Date:  1980

3.  In vitro activities of miconazole, miconazole nitrate, and ketoconazole alone and combined with rifampin against Candida spp. and Torulopsis glabrata recovered from cancer patients.

Authors:  M R Moody; V M Young; M J Morris; S C Schimpff
Journal:  Antimicrob Agents Chemother       Date:  1980-05       Impact factor: 5.191

4.  Combined effect of amphotericin B and rifampin on Candida species.

Authors:  J E Edwards; J Morrison; D K Henderson; J Z Montgomerie
Journal:  Antimicrob Agents Chemother       Date:  1980-03       Impact factor: 5.191
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.